In the coming days when Endo International closes on its $2.6 billion buyout of the successful men’s health specialty biopharmaceutical company just up the road in Chesterbrook, Auxilium’s half a dozen top executives will cash out more than $31 million in stock options and severance payments.
Atop the list is CEO Adrian Adams, who stands to take home $15.5 million, according to a report in the Philadelphia Business Journal.
Auxillium product Stendra treats symptoms of ED.Others reaping a big payday include Auxilium’s chief administrative officer, chief medical officer, executive vice president of corporate development, chief financial officer, former chief financial officer and a handful of significant investors: Deerfield Management, Palo Alto Investors, BlackRock and The Vanguard Group.
Read more about the men behind Auxilium’s big day and the amounts they’re set to collect in the Philadelphia Business Journal here.
